Project description:We report the profiling of small RNAs from Methanopyrus kandleri by high throughput sequencing. Over 83 million Illumina Hi Seq2000 reads were obtained for six independent RNA libraries. The reads were mapped to the M. kandleri AV19 genome (Genbank: NC_003551, 1694969 bp). The small RNome of M. kandleri was analyzed.
Project description:We report the profiling of small RNAs from Methanopyrus kandleri by high throughput sequencing. Over 83 million Illumina Hi Seq2000 reads were obtained for six independent RNA libraries. The reads were mapped to the M. kandleri AV19 genome (Genbank: NC_003551, 1694969 bp). The small RNome of M. kandleri was analyzed. Analysis of small RNome from six Methanopyrus kandleri RNA samples
Project description:Background: Ependymomas encompass multiple, clinically relevant tumor types based on localization and molecular profiles. Although tumors of the methylation class “spinal ependymoma” (SP-EPN) represent the most common intramedullary neoplasms in children and adults, their developmental origin is ill-defined, molecular data are scarce, and the potential heterogeneity within SP-EPN remains unexplored. The only known recurrent genetic events in SP-EPN are loss of chromosome 22q and NF2 mutations, but neither types and frequency of these alterations nor their clinical meaning have been described in a large, epigenetically defined series. Methods: We mapped SP-EPN transcriptomes (n=76) to developmental atlases of the developing and adult spinal cord to uncover potential developmental origins of these tumors. In addition, transcriptomic, epigenetic (n=234), genetic (n=140), and clinical analyses (n=115) were integrated for a detailed overview on this entity. Results: Integration of transcriptomic ependymoma data with single-cell atlases of the spinal cord identified mature adult ependymal cells to display highest similarities to SP-EPN. Unsupervised hierarchical clustering of tumor data together with integrated analysis of methylation profiles identified two molecular SP-EPN subtypes. Subtype 1 predominantly contained NF2 wild type sequences with regular NF2 expression but revealed more extensive copy number alterations. Subtype 2 harbored previously known germline or sporadic NF2 mutations and was NF2-deficient in most cases, more often showed multilocular disease, and demonstrated a significantly reduced progression-free survival. Conclusion: Based on integrated molecular profiling of a large tumor series we identify two distinct SP-EPN subtypes with important implications for genetic counseling, patient surveillance, and drug development priorities.
